PRL and prostate carcinoma: The KEGG enrichment analysis revealed 141 potential pathways, and the 10 most significantly enriched pathways (Figure 2D) included prostate cancer, Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling, non-small cell lung cancer, prolactin signaling, lipid, and atherosclerosis (Liu et al., 2023).